$3.11 Billion is the total value of Boxer Capital, LLC's 78 reported holdings in Q4 2020. The portfolio turnover from Q3 2020 to Q4 2020 was 41.3% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| MRTX | MIRATI THERAPEUTICS INC | $387,788,000 | +32.3% | 1,765,560 | 0.0% | 12.46% | +23.0% | |
| BGNE | BEIGENE LTDsponsored adr | $287,895,000 | -9.8% | 1,114,188 | 0.0% | 9.25% | -16.1% | |
| SWTX | SPRINGWORKS THERAPEUTICS INC | $150,545,000 | +52.1% | 2,075,905 | 0.0% | 4.84% | +41.5% | |
| ITOS | ITEOS THERAPEUTICS INC | $146,948,000 | +37.1% | 4,345,016 | 0.0% | 4.72% | +27.5% | |
| PMVP | PMV PHARMACEUTICALS INC | $139,519,000 | +73.3% | 2,268,236 | 0.0% | 4.48% | +61.2% | |
| RVMD | REVOLUTION MEDICINES INC | $131,014,000 | +13.8% | 3,309,264 | 0.0% | 4.21% | +5.8% | |
| ODT | Buy | ODONATE THERAPEUTICS INC | $107,656,000 | +53.9% | 5,607,086 | +7.7% | 3.46% | +43.2% |
| SAGE | SAGE THERAPEUTICS INC | $94,642,000 | +41.5% | 1,094,000 | 0.0% | 3.04% | +31.6% | |
| RCKT | ROCKET PHARMACEUTICALS INC | $80,398,000 | +139.9% | 1,466,051 | 0.0% | 2.58% | +123.1% | |
| SBTX | New | SILVERBACK THERAPEUTICS INC | $77,637,000 | – | 1,675,377 | +100.0% | 2.50% | – |
| SGEN | SEATTLE GENETICS INC | $70,056,000 | -10.5% | 400,000 | 0.0% | 2.25% | -16.7% | |
| BDTX | BLACK DIAMOND THERAPEUTICS I | $64,576,000 | +6.0% | 2,014,858 | 0.0% | 2.08% | -1.4% | |
| LABD | Buy | DIREXION SHS ETF TRdaily s&p biotec | $56,858,000 | +281.1% | 2,250,000 | +800.0% | 1.83% | +254.3% |
| RCUS | ARCUS BIOSCIENCES INC | $54,124,000 | +51.5% | 2,084,883 | 0.0% | 1.74% | +40.9% | |
| RLAY | Buy | RELAY THERAPEUTICS INC | $53,784,000 | +0.9% | 1,294,132 | +3.4% | 1.73% | -6.2% |
| FOLD | AMICUS THERAPEUTICS INC | $53,684,000 | +63.5% | 2,325,000 | 0.0% | 1.73% | +52.2% | |
| SNDX | SYNDAX PHARMACEUTICALS INC | $50,880,000 | +50.7% | 2,287,782 | 0.0% | 1.64% | +40.2% | |
| ARGX | ARGENX SEsponsored adr | $50,268,000 | +12.0% | 170,926 | 0.0% | 1.62% | +4.2% | |
| PASG | PASSAGE BIO INC | $49,307,000 | +95.0% | 1,928,315 | 0.0% | 1.58% | +81.4% | |
| CYTK | New | CYTOKINETICS INC | $43,638,000 | – | 2,100,000 | +100.0% | 1.40% | – |
| KNTE | New | KINNATE BIOPHARMA INC | $42,352,000 | – | 1,064,665 | +100.0% | 1.36% | – |
| ALGS | New | ALIGOS THERAPEUTICS INC | $42,195,000 | – | 1,526,048 | +100.0% | 1.36% | – |
| NRIX | Sell | NURIX THERAPEUTICS INC | $40,274,000 | -14.8% | 1,224,892 | -9.6% | 1.30% | -20.7% |
| BCEL | ATRECA INC | $35,568,000 | +15.6% | 2,202,333 | 0.0% | 1.14% | +7.5% | |
| KURA | KURA ONCOLOGY INC | $34,302,000 | +6.6% | 1,050,289 | 0.0% | 1.10% | -0.8% | |
| SLDB | Buy | SOLID BIOSCIENCES INC | $32,098,000 | +932.1% | 4,234,574 | +176.4% | 1.03% | +864.5% |
| PAND | PANDION THERAPEUTICS INC | $31,297,000 | +29.6% | 2,107,513 | 0.0% | 1.01% | +20.5% | |
| IDYA | IDEAYA BIOSCIENCES INC | $30,839,000 | +11.5% | 2,202,812 | 0.0% | 0.99% | +3.7% | |
| AMRN | Sell | AMARIN CORP PLCspons adr new | $29,340,000 | -0.4% | 6,000,000 | -14.3% | 0.94% | -7.4% |
| MARINUS PHARMACEUTICALS INC | $29,280,000 | -5.1% | 2,400,000 | 0.0% | 0.94% | -11.7% | ||
| RNA | AVIDITY BIOSCIENCES INC | $28,616,000 | -9.3% | 1,121,327 | 0.0% | 0.92% | -15.7% | |
| ANAB | ANAPTYSBIO INC | $27,950,000 | +45.8% | 1,300,000 | 0.0% | 0.90% | +35.4% | |
| PRVL | PREVAIL THERAPEUTICS INC | $25,910,000 | +126.6% | 1,123,105 | 0.0% | 0.83% | +110.9% | |
| KDMN | KADMON HLDGS INC | $25,754,000 | +5.9% | 6,205,882 | 0.0% | 0.83% | -1.5% | |
| MRUS | New | MERUS N V | $25,030,000 | – | 1,427,849 | +100.0% | 0.80% | – |
| GOSS | GOSSAMER BIO INC | $24,778,000 | -22.1% | 2,562,358 | 0.0% | 0.80% | -27.6% | |
| BCAB | New | BIOATLA INC | $23,343,000 | – | 686,347 | +100.0% | 0.75% | – |
| CBAY | CYMABAY THERAPEUTICS INC | $22,960,000 | -20.7% | 4,000,000 | 0.0% | 0.74% | -26.3% | |
| MREO | Buy | MEREO BIOPHARMA GROUP PLCads | $22,291,000 | +111.1% | 6,226,673 | +54.5% | 0.72% | +96.4% |
| BMRN | BIOMARIN PHARMACEUTICAL INC | $21,923,000 | +15.3% | 250,000 | 0.0% | 0.70% | +7.3% | |
| AKRO | AKERO THERAPEUTICS INC | $21,453,000 | -16.2% | 831,495 | 0.0% | 0.69% | -22.0% | |
| NLTX | NEOLEUKIN THERAPEUTICS INC | $21,165,000 | +17.5% | 1,501,058 | 0.0% | 0.68% | +9.3% | |
| RACA | THERAPEUTICS ACQUISITION COR | $20,880,000 | -3.2% | 1,500,000 | 0.0% | 0.67% | -9.9% | |
| CABA | Buy | CABALETTA BIO INC | $20,010,000 | +17.9% | 1,603,361 | +2.4% | 0.64% | +9.5% |
| CDAK | New | CODIAK BIOSCIENCES INC | $19,466,000 | – | 602,650 | +100.0% | 0.63% | – |
| CLDX | CELLDEX THERAPEUTICS INC NEW | $17,520,000 | +18.1% | 1,000,000 | 0.0% | 0.56% | +10.0% | |
| MIST | Buy | MILESTONE PHARMACEUTICALS IN | $16,597,000 | +27.6% | 2,477,194 | +39.4% | 0.53% | +18.7% |
| MTNB | MATINAS BIOPHARMA HLDGS INC | $15,611,000 | +77.5% | 11,478,634 | 0.0% | 0.50% | +65.1% | |
| PSTX | POSEIDA THERAPEUTICS INC | $13,724,000 | +23.7% | 1,251,055 | 0.0% | 0.44% | +15.1% | |
| DBVT | DBV TECHNOLOGIES S Asponsored adr | $13,035,000 | 0.0% | 7,534,598 | 0.0% | 0.42% | -6.9% | |
| ESPR | Sell | ESPERION THERAPEUTICS INC NE | $13,000,000 | -64.1% | 500,000 | -48.7% | 0.42% | -66.6% |
| AGEN | AGENUS INC | $12,720,000 | -20.5% | 4,000,000 | 0.0% | 0.41% | -26.0% | |
| CERE | New | CEREVEL THERAPEUTICS HLDNG I | $11,846,000 | – | 714,500 | +100.0% | 0.38% | – |
| SPPI | SPECTRUM PHARMACEUTICALS INC | $11,367,000 | -16.4% | 3,333,333 | 0.0% | 0.36% | -22.3% | |
| SELB | SELECTA BIOSCIENCES INC | $9,951,000 | +22.2% | 3,284,072 | 0.0% | 0.32% | +13.9% | |
| PANA | PANACEA ACQUISITION CORPcl a | $9,360,000 | +4.5% | 800,000 | 0.0% | 0.30% | -2.9% | |
| BLU | BELLUS HEALTH INC NEW | $9,104,000 | +34.8% | 2,975,000 | 0.0% | 0.29% | +25.8% | |
| ASMB | New | ASSEMBLY BIOSCIENCES INC | $9,075,000 | – | 1,500,000 | +100.0% | 0.29% | – |
| QURE | Sell | UNIQURE NV | $9,033,000 | -68.0% | 250,000 | -67.3% | 0.29% | -70.2% |
| FSDC | FS DEV CORP | $7,700,000 | -1.8% | 700,000 | 0.0% | 0.25% | -8.5% | |
| MEIP | MEI PHARMA INC | $7,691,000 | -15.4% | 2,913,091 | 0.0% | 0.25% | -21.3% | |
| ORIC | New | ORIC PHARMACEUTICALS INC | $6,770,000 | – | 200,000 | +100.0% | 0.22% | – |
| ARYB | New | ARYA SCIENCES ACQUISTION CO | $6,510,000 | – | 600,000 | +100.0% | 0.21% | – |
| VINC | New | VINCERA PHARMA INC | $6,273,000 | – | 300,000 | +100.0% | 0.20% | – |
| BLSA | New | BCLS ACQUISITION CORP | $6,005,000 | – | 500,000 | +100.0% | 0.19% | – |
| MIRM | MIRUM PHARMACEUTICALS INC | $5,535,000 | -9.4% | 317,000 | 0.0% | 0.18% | -15.6% | |
| JYAC | New | JIYA ACQUISITION CORP | $5,150,000 | – | 500,000 | +100.0% | 0.17% | – |
| KNSA | KINIKSA PHARMACEUTICALS LTD | $5,134,000 | +15.3% | 290,577 | 0.0% | 0.16% | +7.1% | |
| HSAQ | HEALTH SCIENCES ACQ CORP 2 | $5,124,000 | +16.5% | 400,000 | 0.0% | 0.16% | +8.6% | |
| TARA | PROTARA THERAPEUTICS INC | $5,065,000 | +43.9% | 209,227 | 0.0% | 0.16% | +33.6% | |
| HLXA | New | HELIX ACQUISITION CORP | $4,548,000 | – | 400,000 | +100.0% | 0.15% | – |
| AGLE | AEGLEA BIOTHERAPEUTICS INC | $4,329,000 | +11.0% | 550,000 | 0.0% | 0.14% | +3.0% | |
| LJPC | LA JOLLA PHARMACEUTICAL CO | $3,456,000 | -3.7% | 890,700 | 0.0% | 0.11% | -10.5% | |
| GNCA | GENOCEA BIOSCIENCES INC | $2,745,000 | +5.7% | 1,134,453 | 0.0% | 0.09% | -2.2% | |
| LSAQ | New | LIFESCI ACQUISITION II CORP | $2,134,000 | – | 200,000 | +100.0% | 0.07% | – |
| CHFWU | New | CONSONANCE HFW ACQUISITION Cunit 99/99/9999 | $2,094,000 | – | 200,000 | +100.0% | 0.07% | – |
| CLRB | CELLECTAR BIOSCIENCES INC | $1,914,000 | +67.7% | 920,000 | 0.0% | 0.06% | +59.0% | |
| ZGNX | ZOGENIX INC | $546,000 | +11.7% | 27,300 | 0.0% | 0.02% | +5.9% | |
| LSACU | Exit | LIFESCI ACQUISITION CORPunit 03/31/2025 | $0 | – | -300,000 | -100.0% | -0.14% | – |
| FULC | Exit | FULCRUM THERAPEUTICS INC | $0 | – | -705,882 | -100.0% | -0.19% | – |
| ARYA | Exit | ARYA SCIENCES ACQUISITION CO | $0 | – | -600,000 | -100.0% | -0.22% | – |
| XENE | Exit | XENON PHARMACEUTICALS INC | $0 | – | -600,000 | -100.0% | -0.23% | – |
| ARVN | Exit | ARVINAS INC | $0 | – | -300,000 | -100.0% | -0.24% | – |
| ZYME | Exit | ZYMEWORKS INC | $0 | – | -165,000 | -100.0% | -0.27% | – |
| RLMD | Exit | RELMADA THERAPEUTICS INC | $0 | – | -300,000 | -100.0% | -0.39% | – |
| GBT | Exit | GLOBAL BLOOD THERAPEUTICS IN | $0 | – | -250,000 | -100.0% | -0.48% | – |
| ACAD | Exit | ACADIA PHARMACEUTICALS INC | $0 | – | -370,000 | -100.0% | -0.53% | – |
| KOD | Exit | KODIAK SCIENCES INC | $0 | – | -275,138 | -100.0% | -0.56% | – |
| CGEN | Exit | COMPUGEN LTDord | $0 | – | -2,383,673 | -100.0% | -1.34% | – |
| ICPT | Exit | INTERCEPT PHARMACEUTICALS IN | $0 | – | -1,176,000 | -100.0% | -1.68% | – |
| ALLK | Exit | ALLAKOS INC | $0 | – | -675,000 | -100.0% | -1.90% | – |
| IMMU | Exit | IMMUNOMEDICS INC | $0 | – | -4,500,000 | -100.0% | -13.22% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-02-16
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| MIRATI THERAPEUTICS INC | 32 | Q3 2023 | 55.2% |
| BEIGENE LTD | 31 | Q3 2023 | 15.6% |
| KURA ONCOLOGY INC. | 24 | Q3 2021 | 4.7% |
| ROCKET PHARMACEUTICALS INC | 23 | Q3 2023 | 5.4% |
| DBV TECHNOLOGIES S A | 23 | Q3 2023 | 3.9% |
| MEI PHARMA INC | 21 | Q2 2023 | 1.4% |
| SYNDAX PHARMACEUTICALS INC | 20 | Q3 2021 | 3.1% |
| GOSSAMER BIO INC | 19 | Q3 2023 | 4.7% |
| ODONATE THERAPEUTICS INC | 18 | Q1 2022 | 12.5% |
| ESPERION THERAPEUTICS INC NE | 18 | Q2 2021 | 11.0% |
View Boxer Capital, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| IDEAYA Biosciences, Inc. | February 14, 2023 | 2,202,812 | 4.6% |
| Milestone Pharmaceuticals Inc. | February 14, 2023 | 698,861 | 2.0% |
| SpringWorks Therapeutics, Inc. | September 19, 2022 | 3,421,541 | 5.7% |
| iTeos Therapeutics, Inc. | May 11, 2022 | 2,154,058 | 6.1% |
| Atreca, Inc. | February 14, 2022 | 2,202,333 | 7.2% |
| Biomea Fusion, Inc. | February 14, 2022 | 1,188,405 | 4.1% |
| Cabaletta Bio, Inc. | February 14, 2022 | 540,000 | 1.9% |
| CymaBay Therapeutics, Inc. | February 14, 2022 | ? | ? |
| DBV Technologies S.A. | February 14, 2022 | 1,067,299 | 1.9% |
| Elevation Oncology, Inc. | February 14, 2022 | 872,780 | 3.8% |
View Boxer Capital, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13G | 2024-04-22 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G | 2024-02-12 |
| 4 | 2024-02-08 |
| SC 13D/A | 2024-02-08 |
| 4 | 2024-01-25 |
| SC 13D/A | 2024-01-25 |
| SC 13G | 2024-01-18 |
| SC 13D/A | 2023-12-18 |
View Boxer Capital, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.